Hemodynamic changes and systemic activation of coagulation and fibrinolysis during controlled endotoxemia in pigs

Thrombosis Research

Volumn 98, Issue 6, 2000, Pages 517-529

  Kutzsche, Stefan ^a   Schlichting, Ellen ^a   Aspelin, Trude ^a   Lyberg, Torstein ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Coagulation; Endotoxemia; Fibrinolysis; Hemostatic disorders; Septic shock; Swine

Indexed keywords

BLOOD CLOTTING FACTOR 7; ENDOTOXIN; FIBRINOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTOXEMIA; FEMALE; FIBRINOLYSIS; HEMODYNAMICS; LUNG GAS EXCHANGE; MALE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK; SWINE;

ANIMALS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD PRESSURE; CARDIAC OUTPUT; ENDOTOXEMIA; ENDOTOXINS; FIBRINOLYSIS; HEMODYNAMIC PROCESSES; LEUKOCYTE COUNT; PLATELET COUNT; SWINE; VASCULAR RESISTANCE;

EID: 0034659362     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00189-4     Document Type: Article

References (42)

1. Jochum M., Witte J., Schiessler H., Selbmann H.K., Ruckdeschl G., Fritz H. Clotting and other plasma factors in experimental endotoxemia. Inhibition of degradation by exogen proteinase inhibitors Eur Surg Res. 13:1981;152-168.
2. van Deventer S.J., Buller H.R., ten Cate J.W., Aarden L.A., Hack C.E., Sturk A. Experimental endotoxemia in humans. Analysis of cytokine release and coagulation, fibrinolytic, and complement pathways Blood. 76:1990;2520-2526.
3. Rivers R.P., Hathaway W.E., Weston W.L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 30:1975;311-316.
4. Lyberg T., Galdal K.S., Evensen S.A., Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol. 53:1983;85-95.
5. Nawroth P.P., Handley D.A., Esmon C.T., Stern D.M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci USA. 83:1986;3460-3464.
6. Semeraro N., Triggiani R., Montemurro P., Cavallo L.G., Colucci M. Enhanced endothelial tissue factor but normal thrombomodulin in endotoxin-treated rabbits. Thromb Res. 71:1993;479-486.
7. Drake T.A., Cheng J., Chang A., Taylor F.B. Jr. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol. 142:1993;1458-1470.
8. Erlich J., Fearns C., Mathison J., Ulevitch R.J., Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun. 67:1999;2540-2546.
9. Todd A.S. The histological localization of fibrinolysin activation. J Pathol Bact. 78:1959;281-283.
10. Loskutoff D.J., Samad F. The adipocyte and hemostatic balance in obesity. Studies of PAI-1 Arterioscler Thromb Vasc Biol. 18:1998;1-6.
11. Michie H.R. The value of animal models in the development of new drugs for the treatment of the sepsis syndrome. J Antimicrob Chemother. 41(Suppl A):1998;47-49.
12. Fink M.P., Heard S.O. Laboratory models of sepsis and septic shock. J Surg Res. 49:1990;186-196.
13. Taylor F.B. Jr., Chang A., Ruf W., Morrissey J.H., Hinshaw L., Catlett R., Blick K., Edgington T.S. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 33:1991;127-134.
14. Taylor F.B. Jr., Chang A., Esmon C.T., D’Angelo A., Vigano-D’Angelo S., Blick K.E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 79:1987;918-925.
15. Suffredini A.F., Harpel P.C., Parrillo J.E. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med. 320:1989;1165-1172.
16. Levi M., ten Cate H., Bauer K.A., van der Poll T., Edgington T.S., Buller H.R., van Deventer S.J., Hack C.E., ten Cate J.W., Rosenberg R.D. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 93:1994;114-120.
17. Borg T., Alvfors A., Gerdin B., Modig J. A porcine model of early adult respiratory distress syndrome induced by endotoxaemia. Acta Anaesthesiol Scand. 29:1985;814-830.
18. Panepinto L.M., Phillips R.W. The Yucatan miniature pig. Characterization and utilization in biomedical research Lab Anim Sci. 36:1986;344-347.
19. Softeland E., Framstad T., Thorsen T., Holmsen H. Porcine platelets in vitro and in vivo studies. Relevance to human thrombosis research Eur J Haematol. 49:1992;161-173.
20. Andersen O.K., Lundgren T.I., Revhaug A., Osterud B., Giercksky K.E. Controlled endotoxinemia in pigs. A suitable model for in vivo studies of some haemodynamic, humoral and cellular reactions. Acta Chir Scand. 150:1984;599-606.
21. Naess F., Roeise O., Pillgram-Larsen J., Ruud T.E., Stadaas J.O., Aasen A.O. Plasma proteolysis and circulating cells in relation to varying endotoxin concentrations in porcine endotoxemia. Circ Shock. 28:1989;89-100.
22. Schlichting E., Lyberg T. Monitoring of tissue oxygenation in shock. An experimental study in pigs Crit Care Med. 23:1995;1703-1710.
23. Antonsson J.B., Boyle C.C., Kruithoff K.L., Wang H.L., Sacristan E., Rothschild H.R., Fink M.P. Validation of tonometric measurement of gut intramural pH during endotoxemia and mesenteric occlusion in pigs. Am J Physiol. 259:1990;G519-G523.
24. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 17:1957;237-246.
25. Godal H.C., Abildgaard U. Gelation of soluble fibrin in plasma by ethanol. Scand J Haematol. 3:1966;342-350.
26. Hvatum M., Prydz H. Studies on tissue thromboplastin. I. Solubilization with deoxycholate. Biochim Biophys Acta. 130:1966;92-101.
27. Hjort P.F. Intermediate reactions in the coagulation of blood with tissue thromboplastin. Scand J Clin Lab Invest. 9(Suppl 27):1957;16-27.
28. Brandtzaeg P., Kierulf P., Gaustad P., Skulberg A., Bruun J.N., Halvorsen S., Sorensen E. Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis. 159:1989;195-204.
29. Fiddian-Green R.G. Studies in splanchnic ischemia and multiple organ failure. Marston A., Bulkley G.B., Fiddian-Green R.G., Haglund U.H. Splanchnic Ischemia and Multiple Organ Failure. 1989;349-363 Edward Arnold, London.
30. Tate R.M., Repine J.E. Neutrophils and the adult respiratory distress syndrome. Am Rev Respir Dis. 128:1983;552-559.
31. Brigham K.L., Staub N.C. Pulmonary edema and acute lung injury research. Am J Respir Crit Care Med. 157:1998;S109-S113.
32. Rottingen J.A., Enden T., Camerer E., Iversen J.G., Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 270:1995;4650-4660.
33. Osterud B., Rapaport S.I. Activation of factor IX by the reaction product of tissue factor and factor VII. Additional pathway for initiating blood coagulation Proc Natl Acad Sci USA. 74:1977;5260-5264.
34. Lyberg T. Cell-associated procoagulant activity. Williams J.G. Multiple Organ Dysfunction Syndrome. Examining the Role of Eicosanoids and Procoagulants. 1996;29-59 R.G. Landes Company, Austin.
35. Osterud B., Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection. Related to an unfavourable prognosis Thromb Haemost. 49:1983;5-7.
36. Andersen O.K., Osterud B., Gaudernack G., Lundgren T.I., Giercksky K.E. Tissue thromboplastin generation in circulating mononuclear phagocytes and development of coagulation disorders during E. coli endotoxinaemia in pigs. Acta Chir Scand. 151:1985;205-211.
37. van Hinsbergh V.W., Bauer K.A., Kooistra T., Kluft C., Dooijewaard G., Sherman M.L., Nieuwenhuizen W. Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin(ogen) degradation products. Blood. 76:1990;2284-2289.
38. van der Poll T., Levi M., Buller H.R., van Deventer S.J., de Boer J.P., Hack C.E., ten Cate J.W. Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med. 174:1991;729-732.
39. Siebeck M., Spannagl M., Hoffmann H., Schramm W., Fritz H. Time dependent release of tissue-type plasminogen activator and plasminogen activator inhibitor into the circulation of pigs during shock. Blood Coagul Fibrinolysis. 2:1991;459-464.
40. Levin E.G. Latent tissue plasminogen activator produced by human endothelial cells in culture. Evidence for an enzyme-inhibitor complex Proc Natl Acad Sci USA. 80:1983;6804-6808.
41. van Hinsbergh V.W., Kooistra T., van den Berg E.A., Princen H.M., Fiers W., Emeis J.J. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo. Blood. 72:1988;1467-1473.
42. Erickson L.A., Ginsberg M.H., Loskutoff D.J. Detection and partial characterization of an inhibitor of plasminogen activator in human platelets. J Clin Invest. 74:1984;1465-1472.